Orah (Juglans regia L.)
BILJNI PREPARATI DIVLJEG ORAHA:
TINKTURE, MATIČNE TINKTURE I ULJANI MACERAT.
Preparati oraha su namenjeni kod problema sa kožom, kao kozmetik, …
BILJNI PREPARATI DIVLJEG ORAHA:
TINKTURA, DIVLJI ORAH HSS SUŠENI LIST, DER 1:5, DIVLJI ORAH HSS SUŠENI PLOD, DER 1:5;
TINKTURA, DIVLJI ORAH TM SVEŽI LIST, DER 1:2, TINKTURA, DIVLJI ORAH TM SVEŽI PLOD, DER 1:2;
MATIČNA TINKTURA, DIVLJI ORAH TM SVEŽI PLOD I LIST, DER 1:2,
ULJANI MACERAT – ORAH OL, DER 1:4.
DEFINITION:
Common walnut mother tincture complies with the requirements of the general technique for the preparation of mother tinctures (see Homoeopathic Preparations (1038) and French Pharmacopoeia Supplement). The mother tincture is prepared with ethanol (65 per cent V/V), using a mixture of equal quantities of leaf and pericarp from the fresh, green fruit of Juglans regia L.
Adjusted content: minimum 0.002 per cent and maximum 0.008 per cent of total quinones derivatives, expressed as juglone (MF: C10H6O3, MW: 174,152840 g/mol−1).)
BILJNI PREPARATI DIVLJEG ORAHA:
TINKTURA, DIVLJI ORAH HSS, hidroetanolni tečni ekstrakt sušenog lista/ nezrelog ploda, DER 1:5 (Ph.Eur.),
TINKTURA, DIVLJI ORAH TM, hidroetanolni tečni ekstrakt svežeg lista/ nezrelog ploda, DER 1:2 (Ph.Fra.),
MATIČNA TINKTURA, DIVLJI ORAH TM, mešavina hidroetanolnih tečnih ekstrakata svežeg lista i nezrelog ploda, DER 1:2 (Ph.Fra.),
ULJANI MACERAT, ORAH OL, macerat svežeg lista/ ploda sa maslinovim uljem, DER 1:4.
Tinctura foliorum juglandis regiae DER 1:5,
Tinctura foliorum juglandis regiae DER 1:2,
Extractum juglandis DER 1:2,
Juglandis folii recentis extractum ethanolicum liquidum DER 1:2,
Maceratum oleosum juglandis DER 1:4.
ATC:
D11AX11 – ostali dermatologici,
P01AX04 – antiparazitici,
– oralni antiseptik.
U skladu sa:
1) Eu. Ph. monografijom: 2946 Juglandis folium
2) European Medicines Agency, 9 July 2013, EMA/HMPC/346737/2011, Committee on Herbal Medicinal Products (HMPC): Community herbal monograph on Juglans regia L., folium
3) European Medicines Agency, 9 July 2013, EMA/HMPC/346740/2011, Committee on Herbal Medicinal Products (HMPC): Assessment report on Juglans regia L., folium
4) Pharmacopée française 2005 ANSM: Juglans regia ad praeparationes homoeopathicas (NOYER pour préparations homéopathiques)
5) Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC as amended (traditional use), DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004.
Biljni preparati u tečnom obliku (nerazblaženi ili razblaženi) za oralnu i lokalnu upotrebu.
a) Juglans regia L., folium (Walnut fresh leaf),
b) Juglans regia L., fructus immaturus (Walnut fresh unripe fruit),
c) Juglans regia L., exocarpium fructus immaturus (Walnut fresh shell unripe fruit).
Sastav:
a) tečni ekstrat (DER 1:5), ekstrakcioni rastvarač etanol 65% (v/v),
b) tečni ekstrat (DER 1:2), ekstrakcioni rastvarač etanol 65% (v/v),
c) tečni ekstrat (DER 1:4), ekstrakcioni rastvarač maslinovo ulje.
Juglans regia L., sadrži 152 hemijska jedinjenja koja ispoljavaju 701 istraženo dejstvo, podaci ažurirani aprila 2017.
Sadržaj:
a) minimalno 0,002% m/m, maksimalno 0,008% m/m, ukupnih hinona (quinone), izraženih kao juglon (juglone) (MF: C10H6O3, MW: 174,152840 g/mol−1).
b) u većoj koncentraciji sadrži askorbinsku kiselinu, hlorogensku kiselinu, β-eudismol, mezo-inozitol, …
c) više od svih biljaka sadrži juglon, a posle kantariona hiperin.
Indikacije:
Biljni preparati su namenjeni poboljšanju opšteg stanja organizma kroz razna naučno dokazana dejstva.
Upotreba kod urogenitalnih, gastrointestinalnih, kožnih i endokrinih tegoba.
Dr. Džems Djuk (Dr. James Duke) u Handbook of Medicinal Herbs, 2nd Ed. (2002). CRC Press, navodi sledeće:
– ima jako dejstvo kod:
dermatoza, dermatofitoza i znojenja, posebno dlanova i tabana, …
– delotvoran kod:
antraksa, ateroskleroze, krvarenja, kašlja, proliva, ekcema, kolagenoza, arteritisa, sinuzitisa, bronhitisa, sede kose, kolere, difterije, tumora i karcinoma (grudi, kolona, intestinuma, bubrega, usta i usne, jetre, želuca, grla, materice, …), kardiopatija, visokog krvnog pritiska, infekcija (bakterijskih – Salmonella, Staphilococcus, Streptococcus, virusnih – Herpes, gljivičnih – mikoza, kandidijaza, infekcije crvima – prstenastim, pljosnatim, … ), inflamacija (upala), upala grla, rinitisa, laringitisa, gingivitisa i stomatitisa, gojaznosti, rana i povreda kože, kao postantibiotička terapija, kod pankreatičnih tegoba – pankreatitisa, analnih fisura i pruritisa, hiperglikemije, dijabetične bolesti, za čišćenje krvi,…
– u narodnoj medicini kod:
akni, adenopatije, alopecija, anemija, artroza, astme, bola u leđima, Beriberija, opekotina, karijesa, katara, grčeva, kondiloma, zatvora, peruti, dijabetesa, ujeda pasa, pauka, zmija, dizenterije, enteritisa, epilepsija, epitelioma, ešerihije, egzantema, fistula, gripa, gastritisa, gihta, konjunktivitisa, zadaha iz usta, glavobolja, gorušice, impotencije, steriliteta, svraba, gube, leukoreje, lupusa, limfoma, trovanja živom, nefroza, nervoza, oftalmije, reumatizma, rahitisa, škrofula, kamena u bubregu, opekotina od sunca, sifilisa, tuberkuloze, bradavica, zadržavanja tečnosti, apcesa, mekog šankra, favusa, …
– spoljašnja primena kod:
ekcema, zarastanje rana od opekotina i povreda, ujeda insekata, dermatoza, čireva, akni, mitasera, eritema i seboreje, …
– upotrebljava se kao:
antiinflamatik, anodin, adstrigent, depurativ, diuretik, laksativ,vermifug, stimulant, holagog, oralni antiseptik, antihemoragik, antimikotik, antineoplastik, litotriptik, insekticid, …
Doziranje i način primene:
do 2 mL (80 kapi) podeljeno u 2 do 4 doze.
Biljni preparat DIVLJI ORAH HSS i TM:
pojedinačna doza: 0,5 – 1 mL, preporučena dnevna doza (PDD): 2 mL.
Oralna (pola sata pre obroka) i lokalna primena.
Biljni preparat DIVLJI ORAH OL:
upotreba na koži: aplicirati na obolelo mesto u tankom sloju ili obliku impregniranog zavoja. Preparat se može razblažiti sa maslinovim uljem u odnosu 1:1 do 1:4:
Napraviti pauzu posle 4 nedelje neprekidne upotrebe.
Po preporukama, preparat postiže najbolje efekte pri upotrebi od 8 do 12 nedelja, duža upotreba je bezbedna uz pauze.
Kontraindikacije:
preosetljivost na aktivne supstance,
preosetljivost na biljke porodice (genus Juglans, family Juglandaceae).
Čuvanje:
na tamnom, suvom i hladnom mestu do 20˚C, van domašaja dece i izlaganja EM zračenju, u dobro zatvorenoj originalnoj ambalaži.
Rok upotrebe: 5 godina, posle prvog otvaranja 6 meseci, ulje 2 godine. Ako se čuva po preporučenim uslovima, rok trajanja je neograničen.
Pakovanje: 50 mL i 100 mL, standardne farmaceutske braon bočice sa dozatorom (kapaljkom) i belim plastičnim sigurnosnim zatvaračem; 0,25 L, 0,5 L, 1L i 5 L na zahtev.
Nutritivne informacije:
DIVLJI ORAH HSS i TM:
energetska vrednost u 100 mL: 1504 kJ/ 360 kcal,
u preporučenoj dnevnoj dozi (PDD) 2 mL: 30kJ/ 7,17 kcal,
suve materije (DR) više od 2,0% (Fr. Ph. HAB).
DIVLJI ORAH OL:
energetska vrednost u 100 mL: 3389 kJ/ 810kcal,
u preporučenoj dnevnoj dozi (PDD) 2 mL: 67,78kJ/ 16,2kcal,
ukupno masti (g) 91,6/ 1,83; od toga zasićenih (g) 13,0/ 0,26;
nezasićenih (g) 70/ 1,40; polunezasićenih (g) 8,6/ 0,17.
Bez konzervanasa, proteina, masti i ugljenih hidrata.
DIVLJI ORAH HSS i TM su rukom rađeni proizvodi.
Matična tinktura DIVLJI ORAH TM ulazi u sastav preparata RESPIRO 30 za kog je analizu na teške metale, pesticide i mikrobiološku ispravnost preparata broj 4603120601 od 29.03.2016. godine izvršila ANAHEM LABORATORIJA BEOGRAD.
TINKTURA, DIVLJI ORAH HSS, hidroetanolni tečni ekstrakt svežeg lista/ nezrelog ploda, DER 1:2,
50 mL – 500,00 RSD; 100 mL – 1000,00 RSD;
TINKTURA, DIVLJI ORAH TM, hidroetanolni tečni ekstrakt svežeg lista/ nezrelog ploda, DER 1:2,
50 mL – 600,00 RSD; 100 mL – 1200,00 RSD;
MATIČNA TINKTURA, DIVLJI ORAH TM, hidroetanolni tečni ekstrakt svežeg lista/ nezrelog ploda, DER 1:2,
50 mL – 600,00 RSD; 100 mL – 1200,00 RSD;
ULJANI MACERAT, DIVLJI ORAH OL, hidroetanolni tečni ekstrakt svežeg lista, DER 1:2,
50 mL – 250,00 RSD; 100 mL – 500,00 RSD;
Napomena: MT, matična tinktura oraha je po definiciji, mešavina podjednakih delova tinktura nezrelog ploda i lista.
(Mixture of equal quantities of leaf and pericarp from the fresh, green fruit of Juglans regia L.)
Podaci ažurirani aprila 2017. Pogledati i ostale informacije na:
http://www.biljni-preparati.com/preparati/orah-juglans-regia-l-2/
Upotreba oraha (Juglans regiaa L.) sa referencama.
Upotreba oraha u tradicionalnoj narodnoj medicini širom sveta:
vermifug, adstrigent, laksativ, skrofula, intelekt, bubrezi, sifilis, tonik, bol (leđa), alternativ, anodin, antihelmintik, antraks, antiskrofulotik, afte, baktericid, zamućenje vida, Ca (grudi), Ca (cerviks), šankr, holagog, kolike, konjunktivitis, kašalj, dentifrice, depurativ, detergent, digestiv, diuretik, dizenterija, ekcem, ejakulacija, favus, hairblack, gorušica, hemostat, impotencija, antiinflamatik, insekticid, intestinum, intoksikacija, noge, leukoreja, litontriptik, pluća, rejuvenator, reumatizam, spermatogeneza, koža, lokalizovan bol, stimulant, nožni prsti, vermicid,
Reference:
ANON. 1974. A barefoot doctor’s manual. DHEW Publication No. (NIH): 75-695.
Steinmetz, E.F. 1957. codex Vegetabilis. Published by the author, Amsterdam.
Singh, M.P., et al. 1979. Medicinal plants of Nepal – Retrospects and prospects. Economic Botany 33(2): 185-198.
Martinez, Maximino. 1969. Las Plantas Medinales de Mexico.
Uphof, J.C. Th. 1968. Dictionary of economic plants. 2nd ed. Verlag von J. Cramer.
Shih-chen, Li. 1973. Chinese medinal herbs. Georgetown Press, San Francisco.
Hartwell, J.L. 1967-71. Plants used against cancer. A survey. Lloydia 30-34.
Yey, S.D.J. 1973. Anticancer Chinese Herbal Medicines. Maerican Journal of Chinese Medicine 1(2): 271-274.
Keys, J.D. 1976. Chinese Herbs. Charles E. Tuttle Co., Tokyo.
Al-Rawi, Ali. 1964. Medicinal Plants of Iraq. Tech. Bull. No. 15. Ministry of Agriculture, Directorate General of Agricultural Research Projects.
Font Query, P. 1979. Plantas Medicinales el Dioscorides Renovado. Editorial Labor, S.A. Barcelona. 5th Ed.
English Walnut (spisak dejstava po broju aktivnih biojedinjenja)
Activities: 701 Chemicals w/Activities: 110 All Chemicals: 152
activity
antioxidant, Cancer-preventive, pesticide, antiinflammatory, antitumor, antibacterial, antiviral, hypocholesterolemic, hepatoprotective, antimutagenic, antiulcer, antiradicular, antiseptic, diuretic, analgesic, antidepressant, antihepatotoxic, hypotensive, antiarthritic, antiherpetic, choleretic, fungicide, vasodilator, immunostimulant, aldose-reductase-inhibitor, antispasmodic, cytotoxic, antidiabetic, anticataract, antiaggregant, anticancer, cardioprotective, antiatherosclerotic, antiHIV, allergenic, antihypertensive, hypoglycemic, antifeedant, calcium-antagonist, antiosteoporotic, insectifuge, apoptotic, FLavor, xanthine-oxidase-inhibitor, calcium-antagonist, antiosteoporotic, essential, antitumor-promoter, antiplaque, antiflu, antiparkinsonian, antiallergic, antiencephalopathic, carcinogenic, antialzheimeran, antiedemic, antiperoxidant, sedative, immunomodulator, antihistaminic, carcinogenic, xyclooxygenase-Inhibitor, anticonvulsant, prostaglandin-synthesis-inhibitor, antieczemic, antifatigue, anxiolytic, antiasthmatic, candidicide, lipoxygenase-Inhibitor, antirheumatic, antiprostatitic, antinitrosaminic, COX-2-Inhibitor, estrogenic, antineuropathic, antiinsomniac, allelochemic, antiperiodontitic, antidermatitic, antiestrogenic, anticoronary, antiPMS, antigingivitic, uricosuric, anticervicaldysplasic, antiprostaglandin, antimigraine, estrogenic, antiinfertility, antineuropathic, antiinsomniac, allelochemic, juvabional, antiperiodontitic, antistaphylococcic, antidermatitic, antiseborrheic, vulnerary, antiaging, vulnerary, antidermatitic, antitumor (lung), antiophidic, laxative, antifertility, ubiquiot, antianaphylactic, serotoninergic, hemostat, antimenopausal, antialcoholic, ACE-Inhibitor, anticarcinomic, antipyretic, antisyndrome-X, antiobesity, chemopreventive, antimalarial, NO-Inhibitor,
Juglans Regia – Gemmotherapy UNDA Homeopathic Remedies
Tinktura oraha 1:5 Florida herbal pharmacy
Table of contents
- Introduction
1.1. Description of the herbal substance(s), herbal preparation(s) or combinations thereof
1.2. Information about products on the market in the Member States
1.3. Search and assessment methodology
- Historical data on medicinal use
2.1. Information on period of medicinal use in the Community
2.2. Information on traditional/current indications and specified substances/preparations
2.3. Specified strength/posology/route of administration/duration of use for relevant preparations and indications
- Non-Clinical Data
3.1. Overview of available pharmacological data regarding the herbal substance(s), herbal preparation(s) and relevant constituents thereof
3.2. Overview of available pharmacokinetic data regarding the herbal substance(s), herbal preparation(s) and relevant constituents thereof
3.3. Overview of available toxicological data regarding the herbal substance(s)/herbal preparation(s) and constituents thereof
3.4. Overall conclusions on non-clinical data
- Clinical Data
4.1. Clinical Pharmacology
4.1.1. Overview of pharmacodynamic data regarding the herbal substance(s)/preparation(s) including data on relevant constituents
4.1.2. Overview of pharmacokinetic data regarding the herbal substance(s)/preparation(s) including data on relevant constituents
4.2. Clinical Efficacy
4.2.1. Dose response studies
4.2.2. Clinical studies (case studies and clinical trials)
4.2.3. Clinical studies in special populations (e.g. elderly and children
4.3. Overall conclusions on clinical pharmacology and efficacy
- Clinical Safety/Pharmacovigilance
5.1. Overview of toxicological/safety data from clinical trials in humans
5.2. Patient exposure
5.3. Adverse events and serious adverse events and deaths
5.4. Laboratory findings
5.5. Safety in special populations and situations
5.6. Overall conclusions on clinical safety
- Overall conclusions
Annex
List of references
- Overall conclusions
The available data are sufficient to include the traditional use of specified preparations of Juglans regia leaves in a monograph of the European Community.
European walnut leaves fulfil the requirement of safe therapeutic use for at least 30 years (15 years within the Community, Directive 2004/24/EC).
Indications for treatment:
1) Traditional herbal medicinal product for mild superficial inflammatory conditions of skin.
2) Traditional herbal medicinal product used in excessive perspiration of hands and feet.
Due to the lack of adequate data on genotoxicity a list entry for Juglans regia leaves cannot be recommended. Benefit/Risk Assessment
There are some concerns about serious side effects with Juglans regia leaves due to presence of juglone.
However, juglone is unstable and in dry leaves it is present only in traces.
There are reported side effects concerning allergic reactions due to the Juglans regia leaves preparations used.
No serious adverse events with a therapeutic posology of the herbal preparations are reported.
Despite the insufficiency of toxicological data, levels of exposure associated with the use of walnut leaves by topical route of administration for limited time most probably have no relevance to human health and do not result in significant risks.
It can be concluded that the benefit/risk assessment for Juglans regia leaves preparations is positive for use in therapeutical dosages in specific conditions of the mild superficial inflammatory conditions of skin and in excessive perspiration of hands and feet.
Izvor: EMEA
Ивана С……… Ја сам наручила уље од ораха од вас- Miroslav Ilic и презадовољна сам. На планини је одлично штитило дечију кожу. Фантастично се показао и у сузбијању ЕКЦЕМА! Сада само уље од ораха користимо. Хвала вам!